A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects
Clinical trial NCT03162900 · COMPLETED
Trial details
- NCT number
- NCT03162900
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-09
- Primary completion
- 2017-09-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.